Pinnacle Associates LTD Has Trimmed Macrogenics (MGNX) Position By $405,535; Enbridge Energy Management L L C Has 1.98 Sentiment

December 7, 2017 - By Vivian Currie

Pinnacle Associates Ltd decreased Macrogenics Inc (MGNX) stake by 3.77% reported in 2017Q2 SEC filing. Pinnacle Associates Ltd sold 23,855 shares as Macrogenics Inc (MGNX)’s stock declined 10.05%. The Pinnacle Associates Ltd holds 609,518 shares with $10.67 million value, down from 633,373 last quarter. Macrogenics Inc now has $701.10M valuation. The stock decreased 0.05% or $0.01 during the last trading session, reaching $19.04. About 195,867 shares traded. MacroGenics, Inc. (NASDAQ:MGNX) has declined 9.76% since December 7, 2016 and is downtrending. It has underperformed by 26.46% the S&P500.

Enbridge Energy Management, L.L.C., through its limited partner interests in Enbridge Energy Partners, L.P., owns and operates crude oil and liquid petroleum transportation and storage assets in the United States. The company has market cap of $1.20 billion. It also owns and operates natural gas gathering, treating, processing, transportation, and marketing assets in the United States. It currently has negative earnings.

Hite Hedge Asset Management Llc holds 4.62% of its portfolio in Enbridge Energy Management, L.L.C. for 894,555 shares. Energy Income Partners Llc owns 10.82 million shares or 3.16% of their US portfolio. Moreover, Oxbow Advisors Llc has 2.39% invested in the company for 879,243 shares. The California-based Kayne Anderson Capital Advisors Lp has invested 1.78% in the stock. Advisory Research Inc, a Illinois-based fund reported 6.52 million shares.

The stock increased 1.67% or $0.22 during the last trading session, reaching $13.38. About 442,331 shares traded. Enbridge Energy Management, L.L.C. (EEQ) has declined 11.33% since December 7, 2016 and is downtrending. It has underperformed by 28.03% the S&P500.

Analysts await MacroGenics, Inc. (NASDAQ:MGNX) to report earnings on February, 27. They expect $1.48 EPS, up 248.00% or $2.48 from last year’s $-1 per share. MGNX’s profit will be $54.50 million for 3.22 P/E if the $1.48 EPS becomes a reality. After $-1.28 actual EPS reported by MacroGenics, Inc. for the previous quarter, Wall Street now forecasts -215.63% EPS growth.

Investors sentiment increased to 1.73 in 2017 Q2. Its up 0.87, from 0.86 in 2017Q1. It increased, as 11 investors sold MGNX shares while 22 reduced holdings. 15 funds opened positions while 42 raised stakes. 27.45 million shares or 1.31% more from 27.10 million shares in 2017Q1 were reported. Deutsche State Bank Ag owns 162,577 shares. The Illinois-based Ubs Asset Mngmt Americas has invested 0% in MacroGenics, Inc. (NASDAQ:MGNX). Rhumbline Advisers has invested 0% in MacroGenics, Inc. (NASDAQ:MGNX). Legal And General Public Ltd reported 7,925 shares. Proshare Lc holds 0% or 20,911 shares in its portfolio. Emerald Advisers Pa invested in 0.33% or 454,345 shares. California State Teachers Retirement System has invested 0% in MacroGenics, Inc. (NASDAQ:MGNX). Baker Bros LP reported 363,676 shares. The Illinois-based Citadel Advisors Lc has invested 0% in MacroGenics, Inc. (NASDAQ:MGNX). Grp Inc One Trading Ltd Partnership invested in 4,000 shares or 0% of the stock. Citigroup owns 0% invested in MacroGenics, Inc. (NASDAQ:MGNX) for 18,975 shares. Emerald Mutual Fund Advisers owns 358,161 shares. Principal Finance Grp Inc, a Iowa-based fund reported 113,425 shares. Jennison Associates Ltd Liability holds 0% of its portfolio in MacroGenics, Inc. (NASDAQ:MGNX) for 189,970 shares. Public Employees Retirement System Of Ohio stated it has 47,715 shares or 0% of all its holdings.

Among 10 analysts covering MacroGenics (NASDAQ:MGNX), 8 have Buy rating, 0 Sell and 2 Hold. Therefore 80% are positive. MacroGenics had 19 analyst reports since August 6, 2015 according to SRatingsIntel. Leerink Swann maintained MacroGenics, Inc. (NASDAQ:MGNX) on Wednesday, October 25 with “Buy” rating. As per Thursday, September 17, the company rating was initiated by Citigroup. The company was downgraded on Monday, August 10 by Zacks. As per Thursday, February 18, the company rating was initiated by Janney Capital. Morgan Stanley initiated the stock with “Equal-Weight” rating in Thursday, February 25 report. Citigroup maintained the stock with “Neutral” rating in Friday, November 10 report. Citigroup upgraded the stock to “Buy” rating in Monday, October 19 report. As per Tuesday, December 20, the company rating was initiated by SunTrust. The rating was downgraded by Citigroup to “Neutral” on Thursday, August 4. The firm earned “Buy” rating on Wednesday, October 25 by BTIG Research.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Twitter Auto Publish Powered By : XYZScripts.com